6 April 2022 - The U.S. FDA said it is aiming to come up with a decision on coronavirus strain selection for the composition of future COVID-19 boosters by June, as a panel of its advisers met on Wednesday to discuss the issue.

"We should be thinking of a May to June time frame here," said Peter Marks, director of FDA's Center for Biologics Evaluation and Research, during the meeting, adding that there is some wiggle room.

Read Reuters article